1. Home
  2. IPSC vs ICLK Comparison

IPSC vs ICLK Comparison

Compare IPSC & ICLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • ICLK
  • Stock Information
  • Founded
  • IPSC 2019
  • ICLK 2009
  • Country
  • IPSC United States
  • ICLK Hong Kong
  • Employees
  • IPSC N/A
  • ICLK N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • ICLK Computer Software: Prepackaged Software
  • Sector
  • IPSC Health Care
  • ICLK Technology
  • Exchange
  • IPSC Nasdaq
  • ICLK Nasdaq
  • Market Cap
  • IPSC 62.1M
  • ICLK 70.9M
  • IPO Year
  • IPSC 2021
  • ICLK 2017
  • Fundamental
  • Price
  • IPSC $0.73
  • ICLK $7.70
  • Analyst Decision
  • IPSC Strong Buy
  • ICLK
  • Analyst Count
  • IPSC 5
  • ICLK 0
  • Target Price
  • IPSC $11.00
  • ICLK N/A
  • AVG Volume (30 Days)
  • IPSC 493.4K
  • ICLK 57.0K
  • Earning Date
  • IPSC 03-13-2025
  • ICLK 11-27-2024
  • Dividend Yield
  • IPSC N/A
  • ICLK N/A
  • EPS Growth
  • IPSC N/A
  • ICLK N/A
  • EPS
  • IPSC N/A
  • ICLK N/A
  • Revenue
  • IPSC $2,684,000.00
  • ICLK $130,443,999.00
  • Revenue This Year
  • IPSC $230.60
  • ICLK $26.49
  • Revenue Next Year
  • IPSC $31.83
  • ICLK $12.11
  • P/E Ratio
  • IPSC N/A
  • ICLK N/A
  • Revenue Growth
  • IPSC 7.88
  • ICLK N/A
  • 52 Week Low
  • IPSC $0.68
  • ICLK $1.03
  • 52 Week High
  • IPSC $5.51
  • ICLK $11.38
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 30.98
  • ICLK 42.86
  • Support Level
  • IPSC $0.72
  • ICLK $7.85
  • Resistance Level
  • IPSC $0.82
  • ICLK $8.26
  • Average True Range (ATR)
  • IPSC 0.06
  • ICLK 0.59
  • MACD
  • IPSC 0.01
  • ICLK -0.14
  • Stochastic Oscillator
  • IPSC 27.43
  • ICLK 14.12

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

About ICLK iClick Interactive Asia Group Limited

iClick Interactive Asia Group Ltd is an enterprise and marketing cloud Platform in China. It offers a consumer full lifecycle solution that addresses client's needs from traffic acquisition, customer relations management, and business decision optimization driven by data analytics in the retail era. It has two operating segments: Marketing Solutions, and Enterprise Solutions. Geographically, it derives the majority revenue from Mainland China and also has a presence in Hong Kong and other countries.

Share on Social Networks: